CU6 Ann: IND Approval by US FDA for Phase II SAR-Bombesin trial - 6th Jun 2022, 9:31am

[annb0t]

CU6 Ann: IND Approval by US FDA for Phase II SAR-Bombesin trial
Price Sensitive: Y
Date: 6th Jun 2022, 9:31am

>>> Read announcement: Google: CU6 Market Announcements